Patents by Inventor Akihiko KANAMOTO

Akihiko KANAMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound having therapeutic activity against mycobacterium avium complex infection, and method for producing same
    Patent number: 11407742
    Abstract: The purpose of the present invention is to provide a novel compound which has antibacterial activity against Mycobacterium avium and Mycobacterium intracellulare that are causative bacteria of MAC infection and which is different in backbone structure from known drugs for treatment of MAC infection. One aspect of the present invention relates to a compound of Formula (I) [where R1 has the same meaning as described in the specification and claims] or a salt thereof, or a solvate thereof. Another aspect of the present invention relates to a method for producing the compound of Formula (I) or a salt thereof, or a solvate thereof, and a therapeutic agent for Mycobacterium avium complex infection (MAC infection), which comprises the compound or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof as an active ingredient.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: August 9, 2022
    Assignees: THE KITASATO INSTITUTE, OP BIO FACTORY CO., LTD.
    Inventors: Hiroshi Tomoda, Nobuhiro Koyama, Akihiko Kanamoto, Junko Hashimoto, Ikuko Kozone
  • MICROALGAE-CONTAINING PRODUCT AND PRODUCTION METHOD THEREFOR
    Publication number: 20220064587
    Abstract: The present invention provides a microalgae product and a production method for the microalgae product. In one embodiment, the present invention provides a method for treating microalgae without an increase in pheophorbide. By this method, provided is a safe microalgae product having reduced pheophorbide. Such a microalgae product provides various healthy, nutritional, and/or cosmetic effects. The present invention also provides a culturing device that enables high-concentration culturing with less bacterial contamination, and thereby enables highly useful culturing of microalgae.
    Type: Application
    Filed: November 18, 2019
    Publication date: March 3, 2022
    Inventors: Akihiko KANAMOTO, Takeshi FUJIWARA, Takafumi WATANABE
  • NOVEL COMPOUND HAVING THERAPEUTIC ACTIVITY AGAINST MYCOBACTERIUM AVIUM COMPLEX INFECTION, AND METHOD FOR PRODUCING SAME
    Publication number: 20200407346
    Abstract: The purpose of the present invention is to provide a novel compound which has antibacterial activity against Mycobacterium avium and Mycobacterium intracellulare that are causative bacteria of MAC infection and which is different in backbone structure from known drugs for treatment of MAC infection. One aspect of the present invention relates to a compound of Formula (I) [where R1 has the same meaning as described in the specification and claims] or a salt thereof, or a solvate thereof. Another aspect of the present invention relates to a method for producing the compound of Formula (I) or a salt thereof, or a solvate thereof, and a therapeutic agent for Mycobacterium avium complex infection (MAC infection), which comprises the compound or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof as an active ingredient.
    Type: Application
    Filed: August 30, 2018
    Publication date: December 31, 2020
    Applicants: THE KITASATO INSTITUTE, OP BIO FACTORY CO., LTD.
    Inventors: Hiroshi TOMODA, Nobuhiro KOYAMA, Akihiko KANAMOTO, Junko HASHIMOTO, Ikuko KOZONE